Skip to main content
Top

Current Nutrition Reports

Issue 1/2013

Content (9 Articles)

Open Access Cancer (MF Leitzmann, Section Editor)

Influence of Obesity and Related Metabolic Alterations on Colorectal Cancer Risk

Krasimira Aleksandrova, Katharina Nimptsch, Tobias Pischon

Cancer (MF Leitzmann, Section Editor)

Evidence for Contributions of Gut Microbiota to Colorectal Carcinogenesis

B. S. Tyler Culpepper, Volker Mai

Open Access Cancer (MF Leitzmann, Section Editor)

The mTOR Pathway and the Role of Energy Balance Throughout Life in Colorectal Cancer Etiology and Prognosis: Unravelling Mechanisms Through a Multidimensional Molecular Epidemiologic Approach

Matty P. Weijenberg, Laura A. E. Hughes, Martijn J. L. Bours, Colinda C. J. M. Simons, Manon van Engeland, Piet A. van den Brandt

Cancer (MF Leitzmann, Section Editor)

Vitamin D and Colorectal Cancer Prevention: A Review of Epidemiologic Studies

Jung Eun Lee

Cancer (MF Leitzmann, Section Editor)

Dietary Patterns and the Risk of Colorectal Cancer

Teresa T. Fung, Lisa S. Brown

Cancer (MF Leitzmann, Section Editor)

Red Meat Intake and Colorectal Cancer Risk: A Summary of Epidemiological Studies

Doris S. M. Chan, Dagfinn Aune, Teresa Norat

Cancer (MF Leitzmann, Section Editor)

Association between Alcohol Consumption and Colorectal Cancer Risk

Manami Inoue

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine